SGLT2 inhibitor for secondary prevention in acute myocardial infarction patients with diabetes mellitus

被引:0
|
作者
Kim, D. B. [1 ]
Kim, H. Y. [1 ]
机构
[1] Catholic Univ Korea, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
    Lyu, Young Sang
    Oh, Seok
    Kim, Jin Hwa
    Kim, Sang Yong
    Jeong, Myung Ho
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [2] Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus
    Young Sang Lyu
    Seok Oh
    Jin Hwa Kim
    Sang Yong Kim
    Myung Ho Jeong
    Cardiovascular Diabetology, 22
  • [3] Cardiovascular Outcome of the SGLT2 Inhibitor in Acute Myocardial Infarction: A Meta-Analysis
    Hu, Siqi
    Tang, Ting
    Yu, Qingwen
    Tong, Xuhan
    You, Yao
    Zhang, Shenghui
    Chen, Chen
    Tang, Jiake
    Wang, Chunyi
    Wang, Hu
    Fu, Xinyan
    Chen, Juan
    Zhang, Xingwei
    Wang, Mingwei
    Liu, Ling
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2025, 26 (02)
  • [4] SGLT2 inhibitor therapy in patients with type-2 diabetes mellitus: is acute kidney injury a concern?
    Megan Leila Baker
    Mark Anthony Perazella
    Journal of Nephrology, 2020, 33 : 985 - 994
  • [5] SGLT2 inhibitor therapy in patients with type-2 diabetes mellitus: is acute kidney injury a concern?
    Baker, Megan Leila
    Perazella, Mark Anthony
    JOURNAL OF NEPHROLOGY, 2020, 33 (05) : 985 - 994
  • [6] SGLT2 inhibitor use in the management of feline diabetes mellitus
    Cook, Audrey K.
    Behrend, Ellen
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2025, 48 : 19 - 30
  • [7] The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
    Pitt, Bertram
    Steg, Gabriel
    Leiter, Lawrence A.
    Bhatt, Deepak L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (03) : 561 - 567
  • [8] Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus
    Kaushal, Shaveta
    Singh, Harmanjit
    Thangaraju, Pugazhenthan
    Singh, Jasbir
    NORTH AMERICAN JOURNAL OF MEDICAL SCIENCES, 2014, 6 (03) : 107 - 113
  • [9] Safety of SGLT2 Inhibitors in Patients with Diabetes Mellitus
    Singh, Mahakpreet
    Sharma, Ruchika
    Kumar, Anoop
    CURRENT DRUG SAFETY, 2019, 14 (02) : 87 - 93
  • [10] Correction to: The Role of Combined SGLT1/SGLT2 Inhibition in Reducing the Incidence of Stroke and Myocardial Infarction in Patients with Type 2 Diabetes Mellitus
    Bertram Pitt
    Gabriel Steg
    Lawrence A. Leiter
    Deepak L. Bhatt
    Cardiovascular Drugs and Therapy, 2022, 36 : 1259 - 1259